DCF — CRYSTAL CLINIC ORTHOPAEDIC CENTER
Enterprise Value: $-392.1M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-392.1M
Enterprise Value
$-121.8M
PV of Cash Flows
$-270.3M
PV of Terminal Value
$-435.4M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $178.5M | $-25.7M | -14.0% | $-33.2M | $-30.2M |
| Year 2 | $183.8M | $-24.6M | -13.0% | $-32.4M | $-26.8M |
| Year 3 | $189.4M | $-23.4M | -12.0% | $-31.4M | $-23.6M |
| Year 4 | $195.0M | $-23.2M | -12.0% | $-31.4M | $-21.5M |
| Year 5 | $200.9M | $-23.4M | -12.0% | $-31.9M | $-19.8M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-392.1M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$173.3M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.14875116392684717
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5